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ABSTRACT 
Objective:  
To create a comparison between the efficiency of 
intravenous ferrous sucrose and Oral ferrous sulphate, 
present in postpartum iron deficiency anemia.  
Study Design: Randomized control experimental study.  
Place and Duration of the Study: The span of this 
study started from May 1st, 2018- December 30th 2018, 
and took place at Postoperative and PostNatal Ward of 
Surgimed Hospital, Lahore. 
Materials and Methods: Around 50 cases of postpartum 
iron deficiency anemia assembled for this analysis and 
were further classified in two groups of 25 participants 
each. Group A was administered 200 mg of intravenous 
ferrous sucrose on second and fourth day of delivery 
(two doses). Group B cases were given 200 mg of oral 
ferrous sulphate daily for 6 weeks. Follow up took place 
at fifteenth and 40thof postpartum, regarding an increase 
in ferritin level and hemoglobin. 
Results: In group A the mean Hb was 8.21±0.37 
gm/dlwithin 24-48 hours of delivery and 8.69±0.59 
gm/dl in group B. In Group A the mean serum ferritin 
level was 10.99±1.54  mcg/L and 11.54±0.78 mcg/L in 
group B. In group A, the mean Hb after 15 days follow 
up was 10.11±1.23 gm/dl and in group B 9.89±0.52 
gm/dl and in group A, the mean serum ferritin level was 
33.12±3.12 mcg/L and in group B 14.69±0.89 mcg/L. In 
group A, the mean Hb after 40 days follow up was 
11.99±0.68 gm/dl and in group B was 11.22±0.41 gm/dl 
and in group A, the mean serum ferritin level was 
45.99±3.89 mcg/L and in group B was 16.79±1.22 
mcg/L. 
Conclusion: Intravenous iron sucrose therapy increases 
the Hb level as well as serum ferritin level swiftly in 
comparison with oral ferrous sulphate in women with 
postpartum anemia deficiency anemia. 
Key Words: oral iron therapy,Postpartum anemia, 
intravenous iron therapy, anemia, iron deficiency 
INTRODUCTION 
Anemia is a serious global health issue, children 
and pregnant, lactating women being the most 
vulnerable. Lack of iron deficiency leads to 
anemia, trailed by the deficiency of folate during 
pregnancy and postpartum. It has an impact on 
health of 50-60% pregnant women in developing 
nations while 18% in developed countries. It is also 
a crucial factor ina reduced work capacity and also 
leads to maternal morbidity. 
Postpartum hemoglobin (Hb) 
Postpartum Iron deficiency anemia has a strong 
impact on socio and economic aspects of a 
female’s quality of life, it may cause a damp on her 
potential to carry out  household tasks and take care 
of her children. It also known to be a major cause 
of reduced exercise tolerance, reduced physical and 
mental work, depression, impaired wound healing, 
depression and death. Depending upon the severity 
and cause, Oral iron, intravenous iron and blood 
transfusion has been utilized to treat iron deficiency 
Anemia. There are numerous risks of allogeneic 
blood transfusionthat limits its utilization in 
extreme anemia. In order to classify patients in two 
categories (normal and abnormal, for iron store 
purpose) Ferritin and HB assessment have been 
clinically used. Gastrointestinal effects by the 
consumption of oral supplementationleads to poor 
compliance, although it is widely 
consumed.Somemajor symptoms of parenteral iron 
therapy are refusal of blood transfusion, intolerable 
gastrointestinal side effects, inadequate intestinal 
absorption.However iron sucrose has proved to be 
harmless and effectual in anemic pregnant and 
postpartum cases, as it has little allergic reaction 
and gradual release of elementary ferrous 
production from the complex.There are no adverse 
reactions of intravenous iron treated for iron 
deficiency anemia of pregnancyinstead itshowed 
tendency to restore iron stores more effectively yet 
faster than that of oral iron. If the oral iron is 
endurable, then parental therapy do not offer 
advantage over oral iron supplementation. Parental 
irony therapy is advantageous of its administration; 
improve HB deficit and increases iron stores. The 
purpose of this analysis is to create a contrast 
between the efficiency of intravenous ferrous 
sucrose and oral ferrous sulphate in postpartum 
iron deficiency anemia. 
MATERIALS AND METHODS 
A randomized controlled trial, regulated at 
postnatal and postoperative wards of Surgimed 
Hospital, Lahire, from May 1st, 2018- December 
30th, 2018. Non-probability convenient technique 
was used for sampling. Women suffering from 
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postpartum anemia (hemoglobin< 10gm/dl to 
7gm/dl and ferritin level< 15 .microgram/l) at 24-
48 hours of delivery and those who deliver 
Singleton were added in the study. Women with 
comorbidities ( sepsis, renal, infections, hectic 
diseases) and those underwent  blood transfusion 
were excluded. There was a selection of 50 anemic 
cases from post natal and post operative Ward of 
Surgimed Hospital, Lahore, following the 24 hours 
of delivery and were further classified into two 
groups of 25 cases each.An informed consent was 
acquired by the patients and the collected data was 
included in the study. Analysis of red call indices, 
hemoglobin %, serum ferritin level and peripheral 
blood smear was conducted within the 24-48 hours 
of delivery and on 15th and 40th day after treatment. 
There were two groups of patients, labeled as 
Group A and Group B by utilizing a random table 
number. Group A was administered intravenous 
ferrous sucrose 200 mg on second and fourth day 
of delivery( only two doses)  while ferrous sucrose 
was given as an infusion in 100 ml 0.9% sodium 
chloride solution for half an hour after test dose. 
The increased rate of hemoglobin and ferritin level 
was observed on 15th and 40th day of postpartum. 
The data was entered and analyzed by usingSpss 
v.10.The applicable variables were compromised of 
parity, age, duration of marriage, hemoglobin 
before delivery, present hemoglobin and serum 
ferritin. They were classified as proportions and 
frequencies, producing mean and standard 
deviations for categorical variable. Increased 
hemoglobin and ferritin levels (the outcome 
variables) were taken into record. A comparison 
between the two treatments   was studied and its 
difference was tested by applying student t-test, for 
statistical significance. A p-value of 0.05 or below 
was agreed as significant. 
RESULTS 
50 patients suffering from iron deficiency anemia 
post delivery were included for this analysis, and 
were further divided in two Groups of 25 patients 
each. Group A was given intravenous ferrous 
sucrose therapy, while Group B was administered 
oral ferrous sulphate therapy. The mean age of the 
patients in group A was 28.12 ± 2.44 years and 
mean age of the patients in group B was 27.34 ± 
2.14 years.  
In the parity, in group A, there were 12 (48%) 
patients of primigravida and 15 (60%) patients of 
multi gravida and in group B, 13 (52%) patients of 
primigravida and 14 (56%) patients of multi 
gravida  
In presenting symptoms, in group A, there were 23 
(92%) patients of weakness, 14 (56%) patients of 
palpitation, 11 (44%) patients of lethargy, 4 (16.%) 
patients of lack of concentration, 3 (12%) patients 
of dizziness and 8 (32%) patients of dyspnea and in 
group B, there were 21 (84%) patients of weakness, 
5 (20%) patients of palpitation, 7 (28%) patients of 
lethargy, 3 (12%) patients of lack of concentration, 
5 (20%) patients of dizziness and 2 (8%) patient of 
dyspnea.  
In group A, the mean Hb within 24-48 hours of 
delivery was 8.21±0.37 gm/dl and in group B was 
8.69±0.59 gm/dl. In group A, the mean HB after 15 
days follow up was 10.11±1.23 gm/dl and in group 
B was 9.89±0.52 gm/dl. In group A, the mean HB 
after 40 days follow up was 11.99±0.68 gm/dl and 
in group B was 11.22±0.41 gm/dl.  
 
Table 1: Comparison of mean hemoglobin levels in followup period 
Follow up 
Group A (Intravenous)  
n=25 
Group B (Oral) n=25 
p value 
Hemoglobin (gm/dl) Hemoglobin (gm/dl) 
Within 24-48 hours 8.21±0.37 8.69±0.59 0.0001 
At 15th day 10.11±1.23 9.89±0.52 0.02 
At 40th day 11.99±0.68 11.22±0.41 0.0001 
 
The mean ferritin within 24-48 hours of delivery was 10.99±1.54 mcg/l in group A and in group B, it was 
11.54±0.78 mcg/l. In group A, the mean serum ferritin level after 15 days follow up was 33.12±3.12 mcg/l and 
in group B was 14.69±0.89 mcg/l. In group A, the mean serum ferritin level after 40 days follow up was 
45.99±3.89 mcg/l and in group b was 16.79±1.22 mcg/l. 
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Table 2: Comparison of mean ferritin levels in followup period 
Follow up 
Group A (Intravenous)  
n=25 
Group B (Oral) n=25 
p value 
Hemoglobin (gm/dl) Hemoglobin (gm/dl) 
Within 24-48 hours 10.99±1.54 11.54±0.78 0.02 
At 15th day 33.12±3.12 14.69±0.89 0.0001 
At 40th day 45.99±3.89 16.79±1.22 0.0001 
DISCUSSION 
The current analysis was conducted on anemic 
patients to compare the difference of results 
between the utilization intravenous ferrous sucrose 
and usage of standard treatment with oral iron. As 
to see wether intravenous method proves to be 
efficient than oral iron.According to our analysis  
the mean hemoglobin within 24-48 hours of 
delivery was 8.21±0.37gm/dl in group A and 
8.69±0.59gm/dl in group B.When  compared with 
the analysis  of Bhandal and Russel that within 24-
48 hours of delivery, mean hemoglobin was 
7.50±0.80 gm/dl in intravenous group and 
7.30±0.90 gm/dl in oral group, which matches with 
our record.on day 15th and 40th We can observe a 
surge in levels of hemoglobin in both treated 
groups but was notably higher in Intravenous 
Group. On the follow up(day 15th) the mean Hb 
increase was 1.9 gm/dl in group A and 1.2 gm/dl in 
group B, similarly in the study of Van Wick et al 
on 15 days follow up the mean Hb increase was 3.0 
gm/dl in intravenous group and 2.0 gm/dl in oral 
group, which matches with our record as 
intravenous ferrous sucrose increases blood 
hemoglobin levels than that of oral iron 
supplementation, also increases store levels. 
Intravenous iron significantly increased 
hemoglobin concentration and decreased  risk for 
red-cell transfusion in anemic patients This 
conceivable benefit is remunerated by a potential 
risk of disease. Our study reveals serum ferritin 
level increased significantly only in the intravenous 
group and in the oral group. Comparable results 
were acquired by the Bhandal and Russel4 due to 
intravenous ferrous sucrose produces increase or 
rapidly blood hemoglobin levels than oral iron 
supplementation and apparently increases iron 
storesexpeditiously.The rate of production of 
hemoglobin and ferritin is lesser in orally 
consumed iron without much of statistical 
differences in intravenous iron. Nonetheless, high 
doses of orally consumed iron result in statistically 
significant increase. 
CONCLUSION 
We have concluded from our analysis that the 
levels of hemoglobin and serum ferritin 
significantly increase by utilizing intravenous iron 
sucrose therapy, more rapidly than consuming oral 
ferrous sulphate. There was a stark contrast 
between the levels of iron in women treated with 
intravenous iron sucrose therapy and those given 
oral iron, even there was a visible difference in the 
40th day of postpartum. During the whole period of 
analysis, we observed that the ferritin levels rise 
swiftly in women treated with intravenous iron than 
those administered oral iron. 
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